4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-030299
SVP, Clinical Diagnostics sold 40,000 shares at $38.01 ($1,520,400)
- SVP, Clinical Diagnostics acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SANG CHARLES SVP, Clinical Diagnostics | 2020-05-15 | Option exercise | +20,000 | $6.32 | $126,400 | 20,000 | D |
| SANG CHARLES SVP, Clinical Diagnostics | 2020-05-15 | Option exercise | +20,000 | $6.55 | $131,000 | 40,000 | D |
| SANG CHARLES SVP, Clinical Diagnostics | 2020-05-15 | Sale | −40,000 | $38.01 | $1,520,400 | 0 | D |
| Derivatives | |||||||
| SANG CHARLES SVP, Clinical Diagnostics | 2020-05-15 | Option exercise · Stock Option (Right to Buy) | −20,000 | 80,000 | D | ||
| SANG CHARLES SVP, Clinical Diagnostics | 2020-05-15 | Option exercise · Stock Option (Right to Buy) | −20,000 | 230,000 | D | ||
| Open-market sales · 40,000 sh · avg $38.01 · $1,520,400 | |||||||
Loading xslF345X03/doc4.xml…